The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Short bowel syndrome (SBS) affects how well the small intestine absorbs nutrients. Surgery, medications, and nutritional support are all part of a comprehensive treatment plan for this condition.

While there’s no cure for Ehlers-Danlos syndrome, treatments and lifestyle changes can help manage symptoms and prevent complications. Classical (cEDS) In this type, the skin is described as ...

There are many things about chronic fatigue syndrome (CFS ... But according to the NHS website, there are treatments that can be effective. The NHS lists three main symptoms of ME, which ...

your doctor will probably send you to a hospital to get treatment. At the hospital, doctors can keep an eye on your condition as they treat the toxic shock syndrome and the symptoms it’s causing.

The disorder is called CerTra syndrome, and it is not hereditary ... the Rogers aren't sure that gene therapy or some other treatment will be available to help her, but with other families ...

Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental ... an incessant feeling of hunger — in kids and adults with Prader-Willi syndrome. The constant ...

Stacy Ward, CEO of the Prader-Willi Syndrome Association | USA ... number and a website for healthcare providers to initiate treatment access. The announcement was followed by an investor ...

The “Penguin” actor explained that he’s terrified what will happen to James if something were to suddenly happen to him or James’ mom, Kim Bordenave.

Aytu BioPharma’s (AYTU) treatment of Marfan syndrome, enzastaurin, received FDA orphan designation, according to a post to the agency’s site. Discover outperforming stocks and invest smarter ...

SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics (NASDAQ:SLNO)’ drug to treat a rare genetic disorder, making it the first treatment available for ...